Literature DB >> 7062778

Symposium on infective endocarditis. III. Endocarditis due to gram-negative bacteria. Report of 56 cases.

J E Geraci, W R Wilson.   

Abstract

At the Mayo Clinic, 56 patients with infective endocarditis caused by gram-negative bacteria were seen from 1958 through 1979, 35 of whom were seen from 1970 through 1979. The patients were categorized into two divisions: those with medical, naturally acquired valve infections (40 [71%]) and those with infective endocarditis after cardiac operation (16 [29%]). The overall cure rate was 82% (46 of 56 patients); 35 of 40 patients (88%) were cured in the medical group, and 11 of 16 patients (69%) were cured in the surgical group. The patients were further classified on the basis of organism: group 1 (33 patients)--infections caused by Haemophilus (18), Actinobacillus actinomycetemcomitans (4), Cardiobacterium hominis (6), Eikenella corrodens (2), Kingella kingii (2), and Bordetella bronchiseptica (1); 32 of these 33 patients (97%) were cured, and 6 of these infections were on prosthetic valves; group 2 (21 patients)--infections caused by enteric aerobic bacilli; 13 of the 21 patients (62%) were cured; group 3 (1 patient)--infection caused by anaerobes (Bacteroides fragilis); this patient died; and group 4 (1 patient)--infection caused by Neisseria gonorrhoeae; this patient was cured. The gram-negative bacteria in the survivors and nonsurvivors and the curative antibiotic regimens were tabulated. Among the 35 survivors in the medical group, a combined antibiotic regimen cured 21 patients (60%) and a single antibiotic agent cured 14 (40%). Among the 11 survivors in the surgical group, combined therapy was given to 8 (73%), a single drug was used once, and operation alone achieved a cure in 2 patients. Compared with past data, the current study indicates an increasing incidence of gram-negative bacterial endocarditis (approximately 10%) and an improving cure rate 82%).

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7062778

Source DB:  PubMed          Journal:  Mayo Clin Proc        ISSN: 0025-6196            Impact factor:   7.616


  36 in total

1.  [S2 Guideline for diagnosis and therapy of infectious endocarditis].

Authors:  C K Naber
Journal:  Z Kardiol       Date:  2004-12

2.  Prevalence and sequence variants of IS481 in Bordetella bronchiseptica: implications for IS481-based detection of Bordetella pertussis.

Authors:  Karen B Register; Gary N Sanden
Journal:  J Clin Microbiol       Date:  2006-10-25       Impact factor: 5.948

3.  Gram-negative endocarditis.

Authors:  Milagros P Reyes; Katherine C Reyes
Journal:  Curr Infect Dis Rep       Date:  2008-07       Impact factor: 3.725

Review 4.  Medical complications of intravenous drug use.

Authors:  M D Stein
Journal:  J Gen Intern Med       Date:  1990 May-Jun       Impact factor: 5.128

5.  Isolation of Bordetella bronchiseptica from blood and a pancreatic abscess.

Authors:  Nancy A Matic; Paul E Bunce
Journal:  J Clin Microbiol       Date:  2015-03-04       Impact factor: 5.948

6.  A case of suppurative peritonitis by a commensal oral organism, Kingella denitrificans, in an adult peritoneal dialysis patient.

Authors:  Nelson Kopyt; Anshul Kumar; Vibha Agrawal
Journal:  Perit Dial Int       Date:  2015 Jan-Feb       Impact factor: 1.756

Review 7.  Kingella kingae: carriage, transmission, and disease.

Authors:  Pablo Yagupsky
Journal:  Clin Microbiol Rev       Date:  2015-01       Impact factor: 26.132

8.  Endocarditis due to Kingella kingae.

Authors:  L Odum; K T Jensen; T D Slotsbjerg
Journal:  Eur J Clin Microbiol       Date:  1984-06       Impact factor: 3.267

9.  Purification and characterization of Eikenella corrodens type IV pilin.

Authors:  B L Hood; R Hirschberg
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

10.  Identification of type 4 pili in Kingella denitrificans.

Authors:  S Weir; C F Marrs
Journal:  Infect Immun       Date:  1992-08       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.